Tower Research Capital (TRC)’s Connect Biopharma Holdings CNTB Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTB
BCM
DMKJ
Tower Research Capital (TRC)'s CNTB Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Connect Biopharma Holdings (CNTB) stake by 744% in Q3 2026, buying an estimated $13.4K and bringing the position to 7,444 shares worth $8.19K. The position accounts for ﹤0.01% of the portfolio, ranked #4421.
Tower Research Capital (TRC) first reported a position in CNTB in Q1 2022 and has held it in 6 quarters since. The position peaked at $21K in Q3 2022. 53 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.
- Tower Research Capital (TRC) held 7,444 shares of Connect Biopharma Holdings worth $8.19K as of Q3 2026.
- Tower Research Capital (TRC) bought 6,562 Connect Biopharma Holdings shares in Q3 2026, an estimated $13.4K.
- Connect Biopharma Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4421 holding.
- Tower Research Capital (TRC) first reported a position in Connect Biopharma Holdings in Q1 2022 and has held it in 6 quarters since.
- Tower Research Capital (TRC)'s Connect Biopharma Holdings position peaked at $21K in Q3 2022.
- 53 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.